Current concepts of radiation treatment of carcinoma in situ of the testis

A Giwercman; H von der Maase; M Rørth; N E Skakkebaek

doi:10.1007/BF00192268

Current concepts of radiation treatment of carcinoma in situ of the testis

A Giwercman, H von der Maase, M Rørth, N E Skakkebaek

25 Citationer (Scopus)

Abstract

During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.

Originalsprog	Engelsk
Tidsskrift	World Journal of Urology
Vol/bind	12
Udgave nummer	3
Sider (fra-til)	125-30
Antal sider	6
ISSN	0724-4983
DOI	https://doi.org/10.1007/BF00192268
Status	Udgivet - 1994
Udgivet eksternt	Ja

Adgang til dokumentet

10.1007/BF00192268

Citationsformater

@article{76282870bc384ddd8b769458a0cf8284,

title = "Current concepts of radiation treatment of carcinoma in situ of the testis",

abstract = "During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.",

keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biopsy, Carcinoma in Situ/drug therapy, Cell Transformation, Neoplastic/radiation effects, Cisplatin/administration & dosage, Combined Modality Therapy, Follow-Up Studies, Humans, Incidence, Leydig Cells/radiation effects, Male, Radiotherapy Dosage, Risk Factors, Testicular Neoplasms/drug therapy, Testis/pathology, Treatment Outcome",

author = "A Giwercman and {von der Maase}, H and M R{\o}rth and Skakkebaek, {N E}",

year = "1994",

doi = "10.1007/BF00192268",

language = "English",

volume = "12",

pages = "125--30",

journal = "World Journal of Urology",

issn = "0724-4983",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "3",

}

TY - JOUR

T1 - Current concepts of radiation treatment of carcinoma in situ of the testis

AU - Giwercman, A

AU - von der Maase, H

AU - Rørth, M

AU - Skakkebaek, N E

PY - 1994

Y1 - 1994

N2 - During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.

AB - During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Biopsy

KW - Carcinoma in Situ/drug therapy

KW - Cell Transformation, Neoplastic/radiation effects

KW - Cisplatin/administration & dosage

KW - Combined Modality Therapy

KW - Follow-Up Studies

KW - Humans

KW - Incidence

KW - Leydig Cells/radiation effects

KW - Male

KW - Radiotherapy Dosage

KW - Risk Factors

KW - Testicular Neoplasms/drug therapy

KW - Testis/pathology

KW - Treatment Outcome

U2 - 10.1007/BF00192268

DO - 10.1007/BF00192268

M3 - Review

C2 - 7951337

SN - 0724-4983

VL - 12

SP - 125

EP - 130

JO - World Journal of Urology

JF - World Journal of Urology

IS - 3

ER -

Current concepts of radiation treatment of carcinoma in situ of the testis

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater